Department of Rehabilitation Medicine, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
Center for Cybernics Research, University of Tsukuba, Tsukuba, Ibaraki, Japan.
J Clin Neurosci. 2019 Oct;68:101-104. doi: 10.1016/j.jocn.2019.07.026. Epub 2019 Jul 20.
To investigate whether Robot Suit HAL treatment (HAL-T) is safe and feasible for gait disorders in adolescents and adults with cerebral palsy (CP). We tested HAL-T in adolescents and adults with bilateral spastic CP (four men, four women; mean age: 18.2 years). Three participants were classified as level III under the Gross Motor Function Classification System (GMFCS), and five were classified as level IV. The participants underwent HAL-T twice per week for 4 weeks. The outcome measures, which were assessed before and after HAL-T, included comfortable gait speed (CGS), step length (SL), cadence, and GMFCS level. Adverse events were noted. All participants completed the HAL-T sessions despite some mild adverse events occurring. The mean increases in CGS, SL, and cadence were 0.19 ± 0.14 m/s (p = 0.006), 0.09 ± 0.08 m (p = 0.020), and 18.0 ± 15.9 steps/min (p = 0.015), respectively. HAL-T is safe and feasible for gait disorders in patients with CP. HAL-T can significantly improve CGS, SL, and cadence and may be effective for improving walking ability in adolescents and adults with CP.
为了探究机器人套装 HAL 疗法(HAL-T)对脑瘫青少年和成人步态障碍是否安全、是否可行。我们对 4 名男性和 4 名女性(平均年龄:18.2 岁)双侧痉挛型脑瘫青少年和成人进行了 HAL-T 测试。其中 3 名参与者根据粗大运动功能分级系统(GMFCS)分级为 III 级,5 名参与者分级为 IV 级。参与者每周接受 HAL-T 治疗 2 次,共 4 周。评估的结果包括治疗前后的舒适步行速度(CGS)、步长(SL)、步频和 GMFCS 分级。并记录不良事件。尽管出现了一些轻微的不良事件,但所有参与者都完成了 HAL-T 治疗。CGS、SL 和步频的平均增加量分别为 0.19±0.14m/s(p=0.006)、0.09±0.08m(p=0.020)和 18.0±15.9 步/min(p=0.015)。HAL-T 治疗脑瘫患者的步态障碍是安全且可行的。HAL-T 可显著改善 CGS、SL 和步频,可能对改善脑瘫青少年和成人的步行能力有效。